| human | Q5 |
| P496 | ORCID iD | 0000-0002-3449-1245 |
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q46465299 | 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells |
| Q51016206 | 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells. |
| Q37786366 | 10 years quality assurance of the dermatologist's procedure. ABD review board part II: 2003-2009. |
| Q44217000 | 1alpha,25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro |
| Q38022499 | 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis |
| Q34500152 | 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines |
| Q42209528 | 25-hydroxvitamin D3 promotes the long-term effect of specific immunotherapy in a murine allergy model |
| Q45851385 | 5 Posttreatment, Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis. |
| Q101238887 | 9-cis retinoic acid and 1.25-dihydroxyvitamin D3 drive differentiation into IgA+ secreting plasmablasts in human naïve B cells |
| Q38773834 | 9-cis retinoic acid modulates the type I allergic immune response |
| Q125416829 | |
| Q51906982 | A 7-step consultation plan for health care workers and hairdressers. |
| Q38969836 | A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults |
| Q52928513 | A cold-response index for the assessment of Raynaud's phenomenon. |
| Q125473332 | A concept for integrated care pathways for atopic dermatitis—A GA2LEN ADCARE initiative |
| Q125423952 | A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio |
| Q52886006 | A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. |
| Q30314246 | A variant of the CXCL11 gene may influence susceptibility to contact allergy, particularly in polysensitized patients |
| Q104619239 | ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - an EAACI-ARIA position paper |
| Q45891261 | Acetylsalicylic acid potentiates passive systemic anaphylaxis in mice |
| Q58798414 | Adrenaline in the Acute Treatment of Anaphylaxis |
| Q39012647 | Allergen and allergy risk assessment, allergen management, and gaps in the European Food Information Regulation (FIR): Are allergic consumers adequately protected by current statutory food safety and labelling regulations? |
| Q96614584 | Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA GroupA in cooperation with the Austrian ARIA GroupB, the Swiss ARIA GroupC, German Society for Applied A |
| Q94501898 | Allergen-Immuntherapie in der aktuellen Covid-19-Pandemiea, b, c |
| Q46198019 | Allergic contact dermatitis beyond IL-1β role of additional family members |
| Q37060546 | Allergological approach to drug hypersensitivity reactions |
| Q37698892 | Allergy for a lifetime? |
| Q48265436 | An efficient method for gene knock-down by RNA interference in human skin mast cells |
| Q64093177 | Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry |
| Q40066764 | Anaphylaxis in children and adolescents: The European Anaphylaxis Registry |
| Q96432211 | Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemiea, b, c: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immu |
| Q39311872 | Apoptotic resistance of human skin mast cells is mediated by Mcl-1. |
| Q43884525 | Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria |
| Q43455078 | Atopic dermatitis and allergic rhinitis--do co-effects in therapy exist? |
| Q45891931 | Atopic dermatitis and food allergy: when and how to test? |
| Q37689681 | Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis |
| Q50856763 | Autocrine IL-10 promotes human B-cell differentiation into IgM- or IgG-secreting plasmablasts. |
| Q33377688 | Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome |
| Q52804612 | Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. |
| Q39824082 | Bortezomib treatment diminishes hazelnut-induced intestinal anaphylaxis in mice |
| Q71815110 | CD40‐mediated lymphotoxin α expression in human B cells is tyrosine kinase dependent |
| Q44746348 | Cabbage allergy: a rare cause of food-induced anaphylaxis |
| Q38130520 | Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis |
| Q27009246 | Causes and risk factors for anaphylaxis |
| Q43730907 | Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. |
| Q34572557 | Classical conditioning and expectancy in placebo hypoalgesia: a randomized controlled study in patients with atopic dermatitis and persons with healthy skin |
| Q53637356 | Clinical efficacy and tolerability of a novel selective corticosteroid in atopic dermatitis--two randomised controlled trials. |
| Q44288364 | Clopidogrel-associated angioedema |
| Q51066354 | Colophony-induced contact dermatitis due to ECG electrodes in an infant. |
| Q56965207 | Commentary on ''dynamic analysis of histamine-mediated attenuation of acetylcholine-induced sweating via GSK3β activation'' |
| Q93381821 | Contact dermatitis and sensitization in professional musicians |
| Q42922781 | Correction required |
| Q43862186 | Decreased retinoid concentration and retinoid signalling pathways in human atopic dermatitis |
| Q46398847 | Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia |
| Q98937673 | Diagnosing, managing and preventing anaphylaxis: systematic review |
| Q39597794 | Dietary docosahexaenoic acid in combination with arachidonic acid ameliorates allergen-induced dermatitis in mice |
| Q51074505 | Dietary polyunsaturated fatty acids and non-digestible oligosaccharides reduce dermatitis in mice. |
| Q52925385 | Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. |
| Q40413302 | Digital ulcers score: a scoring system to assess digital ulcers in patients suffering from systemic sclerosis |
| Q52936537 | Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. |
| Q35352582 | Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis |
| Q39122316 | Dupilumab in the treatment of moderate-to-severe atopic dermatitis |
| Q39705730 | Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD). |
| Q39907084 | Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study |
| Q53014260 | Effects of Various Synthetic Retinoids on Proliferation and Immunophenotype of Human Melanoma Cells In Vitro |
| Q38938948 | Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial |
| Q90664925 | Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: A 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension |
| Q44621485 | Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis |
| Q92986801 | Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study |
| Q50501197 | Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. |
| Q46903665 | Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus |
| Q46712893 | Efficacy of tracrolimus 0.1% ointment in prurigo |
| Q34250175 | Elicitors and co-factors in food-induced anaphylaxis in adults |
| Q113799110 | Elicitors and phenotypes of adult patients with proven IgE‐mediated food allergy and non‐immune‐mediated food hypersensitivity to food additives |
| Q47434268 | Endogenous Calcitriol Synthesis Controls the Humoral IgE Response in Mice |
| Q34118748 | Epidemiology of anaphylaxis |
| Q96304043 | Epinephrine delivery via EpiPen® Auto-Injector or manual syringe across participants with a wide range of skin-to-muscle distances |
| Q52806193 | Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register. |
| Q51832131 | Evidence for novel tomato seed allergens: IgE-reactive legumin and vicilin proteins identified by multidimensional protein fractionation-mass spectrometry and in silico epitope modeling. |
| Q45389526 | Exogenous histamine aggravates eczema in a subgroup of patients with atopic dermatitis |
| Q39079739 | Exploratory analysis of CD63 and CD203c expression in basophils from hazelnut sensitized and allergic individuals |
| Q50109434 | Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of Data from The European Anaphylaxis Registry |
| Q46898490 | Fatty acid composition of serum lipid classes in mice following allergic sensitisation with or without dietary docosahexaenoic acid-enriched fish oil substitution |
| Q52929910 | Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. |
| Q56965115 | Food allergies resulting from immunological cross-reactivity with inhalant allergens: Guidelines from the German Society for Allergology and Clinical Immunology (DGAKI), the German Dermatology Society (DDG), the Association of German Allergologists ( |
| Q45891646 | Food anaphylaxis and augmentation factors – data of the German-speaking anaphylaxis registry |
| Q31105062 | Food-induced anaphylaxis - data from the anaphylaxis registry |
| Q57025882 | Food-induced fatal anaphylaxis: from epidemiological data to general prevention strategies |
| Q52933178 | Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. |
| Q45102859 | Frequency of contact allergy in German children and adolescents patch tested between 1995 and 2002: results from the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group |
| Q35840816 | Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features |
| Q37805604 | GA² LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma |
| Q112639933 | Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus |
| Q47840482 | Genomewide association study identifies GALC as susceptibility gene for mucous membrane pemphigoid |
| Q37693860 | German guideline for the management of adverse reactions to ingested histamine: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the Germa |
| Q40946338 | German guidelines for the diagnosis and therapy of localized scleroderma |
| Q89706980 | Good tolerability when switching from an aqueous ultra-rush Hymenoptera venom immunotherapy to a depot preparation |
| Q35777144 | Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental Medici |
| Q35777131 | Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergolo |
| Q34986496 | Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. |
| Q51540185 | Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology. |
| Q56965111 | Guidelines on the management of IgE-mediated food allergies: S2k-Guidelines of the German Society for Allergology and Clinical Immunology (DGAKI) in collaboration with the German Medical Association of Allergologists (AeDA), the German Professional A |
| Q41813956 | Human Langerhans cells control Th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy |
| Q43886345 | Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule |
| Q52901265 | Identification of IgE binding to Api g 1-derived peptides. |
| Q28304405 | Immunoglobulin E-reactivity of wheat-allergic subjects (baker's asthma, food allergy, wheat-dependent, exercise-induced anaphylaxis) to wheat protein fractions with different solubility and digestibility |
| Q91879366 | Immunomodulation by vitamin D |
| Q39119733 | Immunomodulation in patients with chronic hand eczema treated with oral alitretinoin |
| Q98200584 | Immunomodulation of high-dose vitamin D supplementation during allergen specific immunotherapy |
| Q44554130 | Immunophenotypic characterization of peripheral B cells. During short-term immunotherapy with tree pollen allergoid and the immunoadjuvant monophosphoryl lipid A. |
| Q52900533 | Impact of arbuscular mycorrhizal fungi on the allergenic potential of tomato. |
| Q38234423 | Impact of comorbidities on the treatment of atopic dermatitis in clinical practice |
| Q44751074 | Impact of sex on anaphylaxis severity--data from the Anaphylaxis Registry |
| Q35891974 | Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study |
| Q28730033 | Implementation of anaphylaxis management guidelines: a register-based study |
| Q71654723 | In vitro sensitivity of human melanoma cells to chemotherapeutic agents and interferons |
| Q30234491 | In-flight allergic emergencies |
| Q43034978 | Increased sensitivity of patch testing by standardized tape stripping beforehand: a multicentre diagnostic accuracy study |
| Q52907994 | Induction of long-lived allergen-specific plasma cells by mucosal allergen challenge. |
| Q43523156 | Influence of bosentan on fingertip rewarming in patients with systemic sclerosis |
| Q45893229 | Inhibition of IgE production by docosahexaenoic acid is mediated by direct interference with STAT6 and NFκB pathway in human B cells |
| Q44224861 | Inhibition of IgE production by the imidazoquinoline resiquimod in nonallergic and allergic donors |
| Q42453138 | Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands |
| Q46634781 | Intake of cardiovascular drugs promote severity of anaphylaxis |
| Q52902894 | Interleukin-17A promotes IgE production in human B cells. |
| Q33687257 | International consensus on (ICON) anaphylaxis |
| Q46604898 | Introducing genetic testing for adult-type hypolactasia |
| Q43980879 | Isolation and phenotypic characterization of mucosal nasal lymphocytes by direct ex vivo analysis |
| Q56973817 | Isolation of Human B Cell Populations |
| Q43687323 | Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group |
| Q47976557 | Liver X receptors control IgE expression in B cells |
| Q44922711 | Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis |
| Q41583969 | Low-dose Anti-thymocyte Globulin Inhibits Human B-cell Differentiation into Antibody-Secreting Cells |
| Q57379223 | Management von Handekzemen Leitlinie ICD-10-Ziffer: L20. L23. L24. L25. L30 |
| Q44293894 | Measurement of proliferative responses of cultured lymphocytes |
| Q45062518 | Meat allergy associated with galactosyl-α-(1,3)-galactose (α-Gal)-Closing diagnostic gaps by anti-α-Gal IgE immune profiling |
| Q45174501 | Modulation of cytokine production by low and high retinoid diets in ovalbumin-sensitized mice |
| Q38837264 | New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs). |
| Q47117802 | New trends in anaphylaxis |
| Q57193201 | Non-celiac gluten/wheat sensitivity (NCGS)-a currently undefined disorder without validated diagnostic criteria and of unknown prevalence: Position statement of the task force on food allergy of the German Society of Allergology and Clinical Immunolo |
| Q35023128 | Novel therapies for atopic eczema |
| Q28245475 | Occupational airborne contact allergy to tetrazepam in a geriatric nurse |
| Q93372025 | Olaparib Desensitization in a Patient with Recurrent Peritoneal Cancer |
| Q43806219 | Opposing effects on immune function and skin barrier regulation by the proteasome inhibitor bortezomib in an allergen-induced eczema model |
| Q54357507 | Oral administration of Escherichia coli Nissle 1917 prevents allergen-induced dermatitis in mice. |
| Q39300012 | Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17-producing T cells |
| Q52927595 | Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG). |
| Q104066882 | Peanut induced anaphylaxis in children and adolescents: data from the European Anaphylaxis Registry |
| Q59341035 | Pemphigus Foliaceus-Repeated Treatment With Rituximab 7 Years After Initial Response: A Case Report |
| Q34769623 | Pepino mosaic virus infection of tomato affects allergen expression, but not the allergenic potential of fruits |
| Q99638689 | Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model |
| Q36257552 | Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol |
| Q37501742 | Polyethylene glycol as a cause of anaphylaxis |
| Q53023155 | Predominance of the major allergen (Alt a I) in Alternaria sensitized patients |
| Q46973002 | Prevalence and treatment profile of patients with grass pollen and house dust mite allergy |
| Q125458991 | Prevalence of tree nut allergy in Europe: A systematic review and meta‐analysis |
| Q35761230 | Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score |
| Q48520183 | Propionibacterium acnes Abundance Correlates Inversely with Staphylococcus aureus: Data from Atopic Dermatitis Skin Microbiome |
| Q33854735 | Provoking allergens and treatment of anaphylaxis in children and adolescents--data from the anaphylaxis registry of German-speaking countries |
| Q92809142 | Proximity-Based Emergency Response Communities for Patients With Allergies Who Are at Risk of Anaphylaxis: Clustering Analysis and Scenario-Based Survey Study |
| Q34051692 | Q&A: Food additive intolerance |
| Q33721881 | Quality indicators for the acute and long-term management of anaphylaxis: a systematic review |
| Q43271413 | Quantitative patch and repeated open application testing in hydroxyisohexyl 3-cyclohexene carboxaldehyde sensitive-patients |
| Q43014918 | Quantitative repeated open application testing with a rinse-off product in methyldibromo glutaronitrile-sensitive patients: results of the IVDK. |
| Q52871840 | Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming. |
| Q56965098 | Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy |
| Q91534328 | Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control |
| Q53842257 | Recommendation: dermatologist's procedure. Recommendations for quality assurance of the German Society of Dermatology (DDG) and the Task Force on Occupational and Environmental Dermatology (ABD). |
| Q36517533 | Research needs in allergy: an EAACI position paper, in collaboration with EFA. |
| Q125489272 | Response to Correspondence to “Short‐course subcutaneous treatment with |
| Q53023355 | Responsiveness to interferon treatment of human melanoma cells correlates to immunophenotype |
| Q38905216 | Retinoic acid potentiates inflammatory cytokines in human mast cells: identification of mast cells as prominent constituents of the skin retinoid network |
| Q122983094 | Rhinitis associated with asthma is distinct from rhinitis alone: The |
| Q52808363 | Risk factors and treatment of refractory anaphylaxis - a review of case reports. |
| Q40947309 | Rituximab preserves vision in ocular mucous membrane pemphigoid |
| Q34953770 | Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis |
| Q42518755 | Role of vitamin A elimination or supplementation diets during postnatal development on the allergic sensitisation in mice |
| Q52865044 | S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid. |
| Q26744978 | S2k guideline on diagnosis and treatment of atopic dermatitis — short version |
| Q40162268 | S2k guideline on diagnosis and treatment of atopic dermatitis--short version |
| Q52863877 | S2k guidelines for the treatment of pemphigus vulgaris/foliaceus and bullous pemphigoid. |
| Q35777045 | S3-Guideline on allergy prevention: 2014 update: Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Society for Pediatric and Adolescent Medicine (DGKJ). |
| Q48012742 | SPIREs: a new horizon for allergic disease treatment? |
| Q42976068 | Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts |
| Q92766087 | Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication |
| Q90481289 | Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry |
| Q38854006 | Serum levels of 9α,11β-PGF2 and apolipoprotein A1 achieve high predictive power as biomarkers of anaphylaxis. |
| Q52863038 | Serum levels of 9α,11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis. |
| Q61807062 | Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab |
| Q125417946 | Short‐course subcutaneous treatment with PQ Grass strongly improves symptom and medication scores in grass allergy |
| Q43112277 | Stringent elimination diet |
| Q37591378 | Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study |
| Q43677966 | Systemic PPARgamma ligation inhibits allergic immune response in the skin |
| Q91988229 | TCRs with segment TRAV9-2 or a CDR3 histidine are overrepresented among nickel-specific CD4+ T cells |
| Q44142604 | The German Multicentre Study on Multiple Chemical Sensitivity (MCS). |
| Q51130295 | The Impact on Allergy-Related Cells of a Birch Pollen Allergoid, with and without Monophosphoryl Lipid A, in Comparison with the Native Equivalent. |
| Q36766918 | The acute and long-term management of anaphylaxis: protocol for a systematic review |
| Q27006976 | The allergic emergency--management of severe allergic reactions |
| Q36937570 | The epidemiology of anaphylaxis in Europe: protocol for a systematic review |
| Q82254839 | The novel protease inhibitor SRD441 ointment is not effective in the treatment of adult subjects with atopic dermatitis: results of a randomized, vehicle-controlled study |
| Q58803466 | The p.Arg435His Variation of IgG3 With High Affinity to FcRn Is Associated With Susceptibility for Pemphigus Vulgaris-Analysis of Four Different Ethnic Cohorts |
| Q41846193 | The placebo effect in allergen-specific immunotherapy trials |
| Q92964869 | The role of mobile health technologies in allergy care: An EAACI position paper |
| Q47657641 | The urgent need for a harmonized severity scoring system for acute allergic reactions |
| Q92697650 | Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways |
| Q39312563 | Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects |
| Q50516322 | Tomato allergy: impact of genotype and environmental factors on the biological response. |
| Q44734732 | Topical immunomodulators for treatment of eczema |
| Q45009222 | Topical therapy of hand eczema - analysis of the prescription profile from dermatologists in private practice |
| Q100402559 | Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2) |
| Q38536150 | Treatment of atopic dermatitis with pimecrolimus - impact on quality of life. |
| Q33822081 | Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland |
| Q47651802 | Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis |
| Q44444401 | Type I sensitization towards patent blue as a cause of anaphylaxis |
| Q98396681 | Usefulness of an artificial neural network to assess anaphylaxis severity |
| Q21145893 | Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis |
| Q40320988 | Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients |
| Q99208332 | Vitamin A controls the allergic response through T follicular helper cell as well as plasmablast differentiation |
| Q52892852 | Vitamin D receptor activation improves allergen-triggered eczema in mice. |
| Q42868319 | Vitamin D receptor binds to the ε germline gene promoter and exhibits transrepressive activity |
| Q52957848 | Wasp venom rush immunotherapy induces transient downregulation of B cell surface molecule expression. |
| Q43003617 | Whole blood flow cytometric measurement of NFATc1 and IL-2 expression to analyze cyclosporine A-mediated effects in T cells |
| Q34368942 | World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base |
| Q52816155 | [Anaphylaxis - Causes, therapy and prevention]. |
| Q52850851 | [Editorial of the special issue Food allergy and other food intolerances : part 2]. |
| Q52852071 | [Editorial of the special issue on food allergies and other food intolerances]. |
| Q52935919 | [Successful treatment of Stewart-Treves syndrome with liposomal doxorubicin]. |
Search more.